Stockscreener 앱 받기
35.89
2.02%
0.71
시간 외 거래:
35.86
-0.03
-0.08%
전일 마감가:
$35.18
열려 있는:
$34.93
하루 거래량:
1.70M
Relative Volume:
1.63
시가총액:
$3.38B
수익:
$4.72M
순이익/손실:
$-277.91M
주가수익비율:
-9.622
EPS:
-3.73
순현금흐름:
$-203.56M
1주 성능:
+1.16%
1개월 성능:
+19.28%
6개월 성능:
+2.34%
1년 성능:
-28.86%
1일 변동 폭
$34.52
$36.87
1주일 범위
$33.27
$36.87
52주 변동 폭
$24.10
$62.53
Crinetics Pharmaceuticals Inc Stock (CRNX) Company Profile
명칭
Crinetics Pharmaceuticals Inc
전화
858-450-6464
주소
6055 LUSK BLVD., SAN DIEGO, CA
CRNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRNX
Crinetics Pharmaceuticals Inc
|
35.89 | 3.31B | 4.72M | -277.91M | -203.56M | -3.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
Crinetics Pharmaceuticals Inc Stock (CRNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 개시 | Goldman | Neutral |
| 2025-03-25 | 개시 | Stifel | Buy |
| 2025-02-11 | 개시 | TD Cowen | Buy |
| 2025-02-04 | 개시 | Wolfe Research | Peer Perform |
| 2025-01-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-03-06 | 개시 | Citigroup | Buy |
| 2024-01-16 | 개시 | Morgan Stanley | Overweight |
| 2023-12-21 | 개시 | Jefferies | Hold |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-10-24 | 재개 | Cantor Fitzgerald | Overweight |
| 2023-08-31 | 개시 | Oppenheimer | Outperform |
| 2023-04-24 | 개시 | Piper Sandler | Overweight |
| 2023-03-30 | 개시 | Robert W. Baird | Outperform |
| 2021-11-30 | 개시 | JMP Securities | Mkt Outperform |
| 2021-11-23 | 개시 | Evercore ISI | Outperform |
| 2021-06-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-23 | 개시 | ROTH Capital | Buy |
| 2019-02-14 | 개시 | H.C. Wainwright | Buy |
| 2018-08-13 | 개시 | JP Morgan | Neutral |
| 2018-08-13 | 개시 | Leerink Partners | Outperform |
| 2018-08-13 | 개시 | Piper Jaffray | Overweight |
모두보기
Crinetics Pharmaceuticals Inc 주식(CRNX)의 최신 뉴스
US FDA approves Crinetics' oral pill for rare hormone disorder - Reuters
FDA Approves Crinetics' (CRNX) PALSONIFY for Acromegaly Treatmen - GuruFocus
FDA approves Crinetics’ once-daily oral acromegaly treatment - Investing.com
Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly - GlobeNewswire
First-Ever Once-Daily Oral Treatment for Acromegaly: Crinetics' PALSONIFY Receives FDA Green Light - Stock Titan
JP Morgan Lowers Price Target for CRNX While Maintaining Overwei - GuruFocus
JPMorgan Chase & Co. Cuts Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $52.00 - MarketBeat
CRNX FDA Catalyst Alert: Could Paltusotine Decision Reshape Endocrine Drug Market? - Nasdaq
Crinetics Pharmaceuticals (NASDAQ:CRNX) Trading Down 4.7%Time to Sell? - MarketBeat
Crinetics Pharmaceuticals, Inc. $CRNX Shares Purchased by Intech Investment Management LLC - MarketBeat
Crinetics Pharmaceuticals, Inc. $CRNX Stock Holdings Trimmed by Voya Investment Management LLC - MarketBeat
Momentum divergence signals in Crinetics Pharmaceuticals Inc. chartWeekly Investment Report & Safe Capital Growth Tips - newser.com
Rhumbline Advisers Increases Position in Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Short interest data insights for Crinetics Pharmaceuticals Inc.2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
CEO Change: What’s the beta of Crinetics Pharmaceuticals Inc. stockLayoff News & Safe Capital Investment Plans - خودرو بانک
Visual analytics tools that track Crinetics Pharmaceuticals Inc. performanceStop Loss & Weekly Top Stock Performers List - newser.com
What Fibonacci levels say about Crinetics Pharmaceuticals Inc. reboundMarket Sentiment Report & Low Risk Profit Maximizing Plans - newser.com
Marquis Who's Who Honors Tiffany P. Quock, PhD, MS, for Expertise in the Pharmaceutical Industry - 24-7 Press Release Newswire
Using fundamentals and technicals on Crinetics Pharmaceuticals Inc.Inflation Watch & High Return Trade Guides - newser.com
What’s next for Crinetics Pharmaceuticals Inc. stock priceShort Setup & Capital Efficiency Focused Strategies - newser.com
Those who invested in Crinetics Pharmaceuticals (NASDAQ:CRNX) five years ago are up 151% - Yahoo Finance
Setup Watch: Can Crinetics Pharmaceuticals Inc be recession proofJuly 2025 Outlook & AI Forecasted Stock Moves - خودرو بانک
Aug Analyst Calls: What is Crinetics Pharmaceuticals Inc.’s TAM (Total Addressable Market)2025 Institutional Moves & Low Risk High Reward Ideas - خودرو بانک
Treasury Yields: What are NXGL’s technical support levelsInflation Watch & Real-Time Stock Movement Alerts - خودرو بانک
Short Covering: Is Crinetics Pharmaceuticals Inc. likely to announce a buybackMarket Activity Summary & High Conviction Buy Zone Alerts - khodrobank.com
Rally Mode: What is the dividend yield of Crinetics Pharmaceuticals Inc2025 Momentum Check & Advanced Technical Analysis Signals - خودرو بانک
Is Crinetics Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Technical Overview & Weekly High Return Forecasts - newser.com
Published on: 2025-09-17 14:31:30 - خودرو بانک
Chart Watch: What is the PEG ratio of Crinetics Pharmaceuticals IncQuarterly Profit Summary & Expert Curated Trade Setups - خودرو بانک
Sell Signal: Should value investors consider Crinetics Pharmaceuticals IncPortfolio Performance Report & Daily Technical Stock Forecast Reports - خودرو بانک
Crinetics Pharmaceuticals Inc. stock trendline breakdownExit Point & Smart Investment Allocation Insights - newser.com
Published on: 2025-09-16 16:37:44 - newser.com
Investment Report: What is the dividend yield of Crinetics Pharmaceuticals IncShort Setup & Reliable Volume Spike Trade Alerts - خودرو بانک
Performance Recap: Is Crinetics Pharmaceuticals Inc a stock for growth or value investorsTrade Analysis Summary & Free Reliable Trade Execution Plans - خودرو بانک
Death Cross: What is Crinetics Pharmaceuticals Inc.’s TAM (Total Addressable Market)Market Growth Review & Real-Time Chart Breakout Alerts - خودرو بانک
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock Price Down 2.7%Time to Sell? - MarketBeat
Using portfolio simulators with Crinetics Pharmaceuticals Inc. included2025 Market Trends & Community Consensus Stock Picks - newser.com
Market Overview: Can SCE Trust VI Preferred Security continue delivering strong returnsLayoff News & Capital Efficiency Focused Strategies - خودرو بانک
Guidance Update: Can Crinetics Pharmaceuticals Inc. outperform under higher oil pricesTrade Volume Summary & Weekly Sector Rotation Insights - خودرو بانک
Volume Report: Is Crinetics Pharmaceuticals Inc. stock a good dividend stock2025 Pullback Review & Long-Term Investment Growth Plans - خودرو بانک
Bearish Setup: Is Crinetics Pharmaceuticals Inc stock a top performer YTD2025 Market Sentiment & Advanced Technical Signal Analysis - خودرو بانک
Exome Asset Management LLC Purchases Shares of 51,295 Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Are Investors Undervaluing Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) By 28%? - 富途牛牛
9 of the Fastest-Growing Biotech Stocks Under $10 Billion - TIKR.com
Dupont Capital Management Corp Sells 561 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - 富途牛牛
Parkman Healthcare Partners LLC Purchases 12,807 Shares of Crinetics Pharmaceuticals, Inc. $CRNX - MarketBeat
Crinetics Pharmaceuticals Inc (CRNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):